Full-Time
Continuous Improvement Engineer 2
Posted on 8/18/2026
Resonetics
1,001-5,000 employees
Laser-based manufacturing services for medical devices
Compensation Overview
$64k - $94k/yr
No H1B Sponsorship
Bethel, CT, USA
In Person
Travel of up to 25% is required.
Bachelor's, Master's
 Operations & Logistics (1) |
|---|
Get referred to Resonetics
See people who can refer or advise you
- Excellent communication, organizational skills, and attention to detail.
- Excellent leadership of individuals at all levels of the organization.
- Excellent analytical, decision-making, and problem-solving skills.
- Comprehensive training in lean manufacturing culture, tools, techniques, and organizational roles necessary for a thriving Enterprise Excellence culture.
- Understanding of project management techniques.
- At least 5 years of experience in a Food and Drug Administration, International Organization for Standardization, or other regulated environment.
- Bachelor of Science or Bachelor of Arts degree in an engineering, science, or related field.
- Thorough knowledge of International Organization for Standardization Quality Systems, particularly in medical device manufacturing.
- Ability to present and convey complex ideas to internal and external customers and stakeholders.
- Ability to work under minimal supervision.
- Lean Black Belt Certification or equivalent.
- Ability to work in both an office and production or cleanroom environment.
- Ability to travel up to 25%.
- Lead implementation and execution of the Resonetics Enterprise Excellence playbook at the local site for all organizational levels.
- Set expectations and coach use of SQCDT boards through tier meetings and weekly SQCDT meetings.
- Lead reviews and coach 8-Step Problem Solving and White, Green, and Black Belt training.
- Support definition of site value streams and organizational support design around those value streams.
- Define metrics and data sources for use on SQCDT boards and ensure the boards use data essential to continuous improvement.
- Work with the site Director of Operations and stakeholders to identify improvement areas and lead Kaizen and problem-solving activities for site priorities.
- Deliver cost savings of at least three times the annual salary through labor, scrap, and overhead improvements.
- Identify and participate in Solve-It risks and opportunities across multiple company projects, and generate and present Enterprise Excellence proposals for stakeholder review.
- Represent the site on the Enterprise Excellence Steering Committee and contribute to the Enterprise Management System.
- Serve as a site Subject Matter Expert for mining, analyzing, and summarizing operational metrics representing Enterprise Excellence key performance indicators.
- Review, analyze, and evaluate business procedures, and implement policies and procedures that improve day-to-day operations.
- Lead coordination and integration of Enterprise Excellence efforts among different company sites, including participation in Kaizens.
- Serve as the site-certified Lean Black Belt and lead the Resonetics Enterprise Excellence certification program.
- Master's degree in business or a related field.
- Six Sigma Black Belt certification.
- Ability to adapt quickly and positively to changing priorities and processes.
- Ability to create job-related documentation.
- Project Management Professional certification.
- Servant-leader mentality.
Resonetics provides advanced manufacturing services for the medical device industry, using laser technologies and vertically integrated capabilities to support medtech and life sciences customers. It conducts rapid prototyping and production of complex medical devices, offering services such as laser cutting, laser welding, and microfluidics. Revenue comes from service contracts and long-term partnerships with medical device companies, including startups and established manufacturers. The company emphasizes continuous improvement through its Enterprise Excellence System to ensure high-quality outcomes and strong customer satisfaction. Compared with competitors, Resonetics differentiates itself through end-to-end vertical integration and a focus on numerically driven decision-making and performance metrics, enabling efficient, reliable manufacturing and faster time-to-market for complex devices.
Company Size
1,001-5,000
Company Stage
Debt Financing
Total Funding
$230.6M
Headquarters
Nashua, New Hampshire
Founded
1987
Get referred to Resonetics
See people who can refer or advise you
Simplify's Take
What believers are saying
- Resolution Medical closed March 23, 2026, adding 240 employees and 100 engineers.
- January 2026 Med-Ally asset acquisition expanded implantable bioelectronics manufacturing capabilities.
- The March 2026 $200 million revolver gives Resonetics liquidity for acquisitions and working capital.
What critics are saying
- California WARN filings show Menlo Park closed April 21, 2026, cutting 61 jobs.
- March 2026 debt amendments pushed the company to a $200 million revolver, increasing leverage dependence.
- Private-equity ownership by Carlyle and GTCR pressures exits, making a 2027 sale or recapitalization likely.
What makes Resonetics unique
- Resonetics combines laser processing, nitinol, and cleanroom assembly across 18 facilities.
- The March 23, 2026 Resolution Medical deal deepens interventional, structural heart, and neuromodulation capabilities.
- Its LightSpeed Labs and AGILE centers accelerate prototyping-to-production cycles for medtech customers.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Performance Bonus
Growth & Insights and Company News
6 month growth
↑ 37%1 year growth
↑ 37%2 year growth
↑ 37%Brian Hanley named president of Applied Plastics. New hire most recently worked at Resonetics. August 13, 2026 Managing Editor Applied Plastics, has recruited Brian Hanley to join the company as president. CEO Tom Barrett will continue in his role through the end of the year and will work closely with Hanley during his transition into the business. "Brian brings the right experience to Applied Plastics," Barrett said. "He has spent more than two decades building and scaling medtech businesses, and he understands both the engineering and the commercial sides of this work. I'll continue as CEO through the end of 2026, and I'll remain involved with the business through my role as an operating partner at Vance Street Capital." The company's PTFE Natural Family of Coating Solutions is used as a critical manufacturing aid and as a functional coating across complex delivery systems and guidewire applications, on components including guidewires, pull wires, mandrels, and hypotubes. Operating from two facilities in Norwood, Mass., Applied Plastics serves OEMs and contract manufacturers worldwide. "Under Tom's leadership, Applied Plastics has grown into a trusted PTFE coating partner to the medtech industry," Vance Street Capital Managing Partner Mike Janish commented. "We are grateful for all he has contributed and glad he will remain involved with the business. Brian's track record in medtech commercialization and operations makes him a valuable addition as the company builds on that success, and we look forward to supporting him and the team in the years ahead." Hanley joins Applied Plastics from Resonetics, where he was vice president of the Lightspeed Lab. He brings more than two decades of medtech experience in interventional and advanced surgical device markets. His background spans product development, operations, quality, and commercialization for Class I, II, and III devices across original equipment manufacturers (OEMs), growth-stage companies, and contract development and manufacturing organizations, including senior leadership roles overseeing R&D and operations. Hanley earned a bachelor of science degree in mechanical engineering and an MBA from Northeastern University. "Applied Plastics has built a strong reputation around its PTFE Natural coating platform and the engineers who depend on it, and I'm looking forward to building on that," Hanley stated. "I want to thank Tom for his support as I join the team. My focus will be on serving our customers with the product performance, quality, and responsiveness they have come to rely on." Applied Plastics is a PTFE coating partner to the medtech industry, supporting customers from concept to commercialization with products and solutions. The PTFE Natural Family of Coating Solutions delivers application-specific, engineered coatings for demanding catheter applications. Whether for core or pull wires, mandrels, or hypotubes, customers can select a coating solution that matches their design requirements. Applied's online store provides quick, easy access to inventory for R&D and process development, with in-stock product shipping within 24 hours. Vance Street Capital is a middle-market private equity firm focused on investing in highly engineered solutions businesses across the medical, life science, industrial technology, and aerospace sectors. Vance Street collaborates with management teams and family owners to drive revenue growth, enhance operational efficiency, and acquire strategic assets for companies within its investment portfolio.
Resonetics, a manufacturing company, has secured $231 million in incremental credit facilities through an amendment to its First Lien Credit Agreement. The financing comprises $220 million in term loans and $10.6 million in revolving credit commitments. Cahill represented the lead arrangers in the transaction. The incremental facilities expand Resonetics' existing credit structure, providing additional liquidity for the company's operations.
Arcline Investment Management has agreed to sell Resolution Medical, a Minnesota-based manufacturer of medical devices and components, to Resonetics. Financial terms were not disclosed. Founded in 2012, Resolution Medical produces devices for medical technology end markets including structural heart, cardiology and vascular, electrophysiology and neuromodulation therapies. The Fridley-based company specialises in manufacturing medical devices and components for these sectors.
/PRNewswire/ -- Arcline Investment Management ("Arcline"), a growth-oriented private equity firm, today announced that it has entered into a definitive...
Resonetics to acquire Resolution Medical, expanding capabilities in neuromodulation and structural heart markets. News provided by. NASHUA, N.H., Jan. 27, 2026 /PRNewswire/ - Resonetics announced today that it has signed an agreement to acquire Resolution Medical, a leading provider of integrated design and manufacturing solutions for complex medical devices. Resolution Medical is headquartered in Fridley, MN, with additional operations in the Netherlands, and is currently owned by Arcline Investment Management. The transaction adds complementary capabilities in high-growth therapeutic markets, including neuromodulation, structural heart, and interventional cardiology to current Resonetics offerings. The acquisition is expected to close in 2026, pending regulatory approvals and customary closing conditions. "Resolution Medical is an exceptional organization with deep technical expertise, a strong innovation culture, and a proven track record in designing and developing complex medical devices for the most innovative companies," said Kevin Kelly, CEO of Resonetics. "This acquisition will enhance our ability to deliver fully integrated solutions for customers in high-growth markets like neuromodulation and structural heart and supports our vision of becoming the most comprehensive partner in the medical device industry." "This acquisition represents the ideal outcome for our customers and for our employees. Our customers will benefit from access to deeper capabilities and a more integrated, expansive partner," said Peter Herman, CEO of Resolution Medical. "By joining Resonetics, our employees also gain access to the skills, resources, and opportunities of a larger organization. Resolution Medical will be able to operate at greater scale and deliver enhanced solutions to our customers while continuing to support their programs with the same teams, expertise, and commitment they rely on today." Resolution Medical brings more than 240 employees, including over 100 engineers, and a strong reputation for delivering high-quality design engineering, new product introduction (NPI), and cleanroom production capabilities. The company supports a wide range of Class II and III devices and has built deep customer relationships, particularly in the neuromodulation and structural heart markets. Backed by funds managed by global investment firm Carlyle and leading private equity firm GTCR, Resonetics provides end-to-end product development and manufacturing services, from prototyping through high-volume production. The addition of Resolution Medical enhances Resonetics' ability to support customers with increasingly complex devices across the full product lifecycle. Until the transaction closes, Resonetics and Resolution Medical will continue to operate independently. Nelson Mullins Riley & Scarborough acted as legal advisor to Resonetics. About Resonetics Founded in 1987, Resonetics is a pioneer in advanced engineering and manufacturing solutions for the medical device industry. Resonetics is a leader in laser processing, nitinol manufacturing, thin-wall stainless steel, nitinol & precious metal tubing, and photochemical machining. With strategically located LightSpeed Labs(R) and AGILE Product Development(R) centers, Resonetics is committed to quality, speed, innovation, and a great customer experience. The company is ISO 13485:2016 certified with 18 facilities and more than 3,000 associates in the United States, Canada, Costa Rica, Israel, and Switzerland. Resonetics is backed by leading private equity firms Carlyle and GTCR. Learn more at www.resonetics.com. About GTCR Founded in 1980, GTCR is a leading private equity firm that invests behind The Leaders Strategy(TM)- finding and partnering with management leaders in core domains to identify, acquire and build market-leading companies through organic growth and strategic acquisitions. GTCR is focused on investing in transformative growth in companies in the Business & Consumer Services, Financial Services & Technology, Healthcare and Technology, Media & Telecommunications sectors. Since its inception, GTCR has invested more than $30 billion in approximately 300 companies, and the firm currently manages approximately $50 billion in equity capital. GTCR is based in Chicago with offices in New York and West Palm Beach. For more information, please visit www.gtcr.com. Follow us on LinkedIn. About Carlyle Carlyle (NASDAQ: CG) is a global investment firm with deep industry expertise that deploys private capital across its business and operates through three segments: Global Private Equity, Global Credit, and Carlyle AlpInvest. With $474 billion of assets under management as of September 30, 2025, Carlyle's purpose is to invest wisely and create value on behalf of its investors, portfolio companies, and the communities in which we live and invest. Carlyle employs more than 2,400 people in 27 offices across four continents. Further information is available at carlyle.com. Follow Carlyle on LinkedIn at The Carlyle Group and on X at @OneCarlyle. SOURCE Resonetics, LLC